Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
EV/Core EBITDA

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
   EV/Core EBITDA(x) 21.6624.4518.2430.428.26

What is the latest EV/Core EBITDA ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest EV/Core EBITDA ratio of SYNCOM FORMULATIONS (INDIA) is 21.66 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202521.66
Mar202424.45
Mar202318.24
Mar202230.42
Mar20178.26

How is EV/Core EBITDA of SYNCOM FORMULATIONS (INDIA) Trending?

Years EV/Core EBITDA % Change
Mar2025 21.66
-11.41
Mar2024 24.45
34.05
Mar2023 18.24
-40.04
Mar2022 30.42
268.28
Mar2017 8.26 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare EV/Core EBITDA ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,311.3 Cr 7.3% 12.7% -17.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,243.0 Cr -1.4% -7.2% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,179.0 Cr 5.7% 0.3% 14.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,670.0 Cr 1.5% -6.5% 28.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,932.0 Cr 0.7% -7.4% 9.9% Stock Analytics
CIPLA ₹99,417.9 Cr 0.5% -7.1% -14.4% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

7.3%

12.7%

-17.2%

SENSEX

0.6%

1.5%

6.6%


You may also like the below Video Courses